NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas

British Journal of Cancer

Volumn 97, Issue 4, 2007, Pages 531-538

  Gorka B ^a   Skubis Zegadlo J ^a   Mikula, M ^b   Bardadin, K ^a   Paliczka, E ^c   Czarnocka, B ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Immunohistochemistry; Neuron glia related cell adhesion molecule; Papillary thyroid carcinoma; Quantitative RTPCR; Western blot

Indexed keywords

CELL ADHESION MOLECULE; NEURON GLIA RELATED CELL ADHESION MOLECULE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY LABELING; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; GLIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS SYSTEM; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID FOLLICLE; THYROID PAPILLARY CARCINOMA; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; THYROID NEOPLASMS; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 34547855851     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603915     Document Type: Article

References (48)

1. Airaksinen MS, Titievsky A, Saarma M (1999) GDNF family neutrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13: 313-325
2. Aitkenhead M, Wang S-J, Nakatsu MN, Mestas J, Heard Ch, Hughes ChCW (2002) Identification of endothelial cell genes expressed in an in vivo model of angiogenesis: induction of ESM-1, βig-h3, and NrCAM. Microvasc Res 63: 159-171
3. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H (2005) The L1 cell adhesion molecule in induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 11: 1190-1197
4. Borello MG, Alberti L, Fischer A, Degl'Innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L, Mantovani A, Pierotti M (2005) Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci USA 102: 14825-14830
5. Brabant G, Hoang-Vu C, Behrends JY, Pötter E, Dumont JE, Meanhaut C (1995) Regulation of the cell - cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro. Endocrinology 136: 3113-3119
6. Cavallaro U, Christofori G (2004) Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-131
7. Christofori G (2003) Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 22: 2318-2323
8. Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T, Ben-ze'ev A (2005) The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res 65: 11605-11612
9. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A (2002a) The cadherin - catenin adhesion system in signaling and cancer. J Clin Invest 109: 987-991
10. Conacci-Sorrell ME, Ben-Yedida T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A (2002b) NrCAM is a target gene of the β-catenin/Lef-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 16: 2058-2072
11. DeLellis RA, Williams ED (2004) Thyroid and parathyroid tumors. In: DeLellis LA, Lloyd RV, Heitz PU, Eng C (eds). Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours. Lyon: IARC Press, pp 51-56
12. Dhodapkar KM, Friedlander D, Scholes J, Grumet M (2001) Differential expression of the cell-adhesion molecule Nr-CAM in hyperplastic and neoplastic human pancreatic tissue. Hum Pathol 32: 396-400
13. Euer NI, Kaul S, Deissler H, Möbus V, Zeillinger R, Weidler UH (2005) Identification of L1CAM, Jagged2 and neuromedin U as ovarian cancer-associated antigens. Oncol Rep 13: 375-387
14. Ezzat S, Asa SL (2005) The molecular pathogenetic role of cell adhesion in endocrine neoplasia. J Clin Pathol 58: 1121-1125
15. Falk J, Thoumine O, Dequidt C, Choquet D, Faivre-Sarrailh C (2004) NrCAM coupling to the cytoskeleton depends on multiple protein domains and partitioning into lipid rafts. Mol Biol Cell 15: 4695-4709
16. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12: 89-96
17. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M, Altevogt P (2003) L1 expression as a predictor of progression and survival in patient with uterine and ovarian carcinoma. Lancet 189: 869-875
18. Glienke J, Schmitt AO, Pilarsky Ch, Hinzman B, Weiß B, Rosenthal A, Thierauch KH (2000) Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem 267: 2820-2830
19. Grumet M, Mauro V, Burgoon MP, Edelman GM, Cunnigham BA (1991) Structure of a new nervous system glycoprotein, Nr-CAM, and its relationship to subgroups of neural cell adhesion molecules. J Cell Biol 113: 1399-1412
20. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357
21. Hirohashi S, Kanai Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581
22. Hortsch M (2000) Structural and functional evolution of the L1 family: are four adhesion molecules better than one? Mol Cell Neurosci 15: 1-10
23. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko-Wojciechowska M, Wloch J, Czarniecka A, Chmielik E, Lange D, Pawlaczek A, Szpak S, Gubala E, Swiernik A (2005) Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65: 1587-1597
24. Kayyem JF, Roman JM, de la Rosa EJ, Schwarz U, Dreyer WJ (1992) Bravo/Nr-CAM Is closely related to the cell adhesion molecules L1 and Ng-CAM and has a similar heterodimer structure. J Cell Biol 118: 1259-1270
25. Kim KH, Kang DW, Kim SH, Seong IO, Kang DY (2004) Mutations of BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45: 818-821
26. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutation in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary carcinoma. Cancer Res 63: 1454-1457
27. Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M (1991) The TRK proto-oncogene encodes a receptor for nerve growth factor. Cell 65: 189-197
28. Lane RP, Chen X-N, Yamakawa K, Vielmetter J, Korenberg JR, Dreyer WJ (1996) Characterization of a highly conserved human homolog to the chicken neural cell surface protein Bravo/NrCAM that maps to chromosome band 7q31. Genomics 35: 456-465
29. Mikula M, Dzwonek A, Jagusztyn-Krynicka K, Ostrowski J (2003) Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Meth 55: 351-359
30. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TL, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S (2003) Clinical implications of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88: 4393-4397
31. Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13: 3-16
32. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikifirov YE (2003) BRAF mutations in thyroid tumours are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88: 5399-5404
33. Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G (2004) Real-time quantitative RT - PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma. Lab Invest 84: 1557-1570
34. Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M (2006) The p75 neutrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Hum Pathol 37: 562-568
35. Sakurai T, Lustig M, Babiarz J, Furley AJW, Tait S, Brophy PJ, Brown SA, Brown LY, Mason CA, Grumet M (2001) Overlapping functions of the cell adhesion molecules Nr-CAM and L1 in cerebellar granule cell development. J Cell Biol 154: 1259-1273
36. Santoro M, Carlomagno F, Melillo RM, Fusco A (2004) Dysfunction of the RET receptor in human cancer. Cell Mol Life Sci 61: 2954-2964
37. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G (2002) Molecular mechanisms of RET activation in human cancer. Ann NY Acad Sci 963: 116-121
38. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, Aldape HC, Simrell CR, Murphy GP (1998) Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer 76: 451-458
39. Skubis-Zegadło J, Nikodemska A, Przytuła E, Mikula M, Bardadin K, Ostrowski J, Wenzel BE, Czarnocka B (2005) Expression of pendrin in benign and malignant human thyroid tissues. Br J Cancer 93: 144-151
40. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simões M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22: 4578-4580
41. Suter DM, Pollerberg GE, Buchstaller A, Giger RJ, Dreyer WJ, Sonderegger P (1995) Binding between the neural cell adhesion molecules axonin-1 and Nr-CAM/Bravo is involved in neuron-glia interaction. J Cell Biol 131: 1067-1081
42. Tallini G (2002) Molecular pathobiology of thyroid neoplasms. Endocr Pathol 13: 271-288
43. Trovisco V, de Castro IV, Soares P, Maximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202: 247-251
44. Trovisco V, Soares P, Sobrinho-Simões M (2006) B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 37: 781-786
45. Wang B, Williams H, Du JS, Terrett J, Kenwrick S (1998) Alternative splicing of human NrCAM in neural and nonneural tissues. Mol Cell Neurosci 10: 287-295
46. Williams EJ, Barclay AN (1988) The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol 6: 381-405
47. Xing M (2005) BRAF mutation in thyroid cancer. Endocr-Relat Cancer 12: 245-262
48. Zelina P, Avci HX, Thelen K, Pollerberg GE (2005) The cell adhesion molecule NrCAM is crucial for growth cone behaviour and pathfinding of retinal ganglion cell axons. Development 132: 3609-3618